The Medical Letter - 2020
Search or Select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Year:    Publication:     
August 10, 2020 (Issue 1604)  
  • IV Artesunate for Severe Malaria   
    Artesunate for injection (Amivas LLC), a semi-synthetic artemisinin derivative, is now approved by the FDA for initial (induction) treatment of severe malaria in children and adults. It has been...
  • Drugs for Menopausal Symptoms   
    The primary symptoms of menopause are genitourinary (genitourinary syndrome of menopause; GSM) and vasomotor (VMS). Vulvovaginal atrophy can cause vaginal burning, irritation and dryness,...
July 27, 2020 (Issue 1603)  
July 13, 2020 (Issue 1602)  
June 29, 2020 (Issue 1601)  
June 15, 2020 (Issue 1600)  
  • Drugs for Atopic Dermatitis   
    Atopic dermatitis (AD; also known as eczema) is frequently associated with other atopic disorders such as allergic rhinitis, asthma, and food allergy. It commonly presents in infancy and early...
June 1, 2020 (Issue 1599)  
May 18, 2020 (Issue 1598)  
  • Drugs for Hypertension   
    Drugs available for treatment of chronic hypertension and their dosages, adverse effects, and costs are listed in the tables. Treatment of hypertensive urgencies and emergencies is not discussed...
May 4, 2020 (Issue 1597)  
April 20, 2020 (Issue 1596)  
April 6, 2020 (Issue 1595)  
March 23, 2020 (Issue 1594)  
March 9, 2020 (Issue 1593)  
February 24, 2020 (Issue 1592)  
  • Drugs for Depression   
    Complete remission of symptoms is the goal of treatment for major depressive disorder; a partial response is associated with an increased risk of relapse. Improvement in symptoms can occur...
February 10, 2020 (Issue 1591)  
January 27, 2020 (Issue 1590)  
January 13, 2020 (Issue 1589)